National Institute on Drug Abuse; Notice of Closed Meetings, 35226 [2011-14868]

Download as PDF 35226 Federal Register / Vol. 76, No. 116 / Thursday, June 16, 2011 / Notices Health, 6701 Rockledge Drive, Room 5208, MSC 7852, Bethesda, MD 20892. (301) 435– 1165. walkermc@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Fellowship: Oncological Sciences. Date: July 18–19, 2011. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Allen Richon, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7892, Bethesda, MD 20892. 301–435– 1024. allen.richon@nih.hhs.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Fellowships: Infectious Diseases and Microbiology. Date: July 18–19, 2011. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Avenue Hotel Chicago, 160 E. Huron Street, Chicago, IL 60611. Contact Person: Alexander D Politis, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 20892. (301) 435– 1150. politisa@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 10, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Children’s Study Advisory Committee. Date: July 20, 2011. Time: 9 a.m. to 5 p.m. Agenda: The major topic to be discussed will be privacy and participant data, a revised sampling strategy, and a high-level discussion of the Main Study protocol. Place: National Institutes of Health, Natcher Conference Center, 45 Center Drive, Room E1/E2, Bethesda, MD 20892. Contact Person: Kate Winseck, MSW, Executive Secretary, National Children’s Study, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5C01, Bethesda, MD 20892, (703) 902– 1339, ncs@circlesolutions.com. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. For additional information about the Federal Advisory Committee meeting, please contact Circle Solutions at ncs@circlesolutions.com. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: June 9, 2011 Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–15005 Filed 6–15–11; 8:45 am] [FR Doc. 2011–14875 Filed 6–15–11; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health srobinson on DSK4SPTVN1PROD with NOTICES Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Children’s Study Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Registration is required since space is limited and will begin at 8 a.m. Please visit the conference Web site for information on meeting logistics and to register for the meeting https:// www.circlesolutions.com/ncs/ncsac/ index.cfm. Individuals who plan to Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 USC, as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which VerDate Mar<15>2010 17:18 Jun 15, 2011 Jkt 223001 PO 00000 Frm 00042 Fmt 4703 Sfmt 9990 would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, 2011 NIDA Avant-Garde Award Program for HIV/ AIDS Research (DP1). Date: June 28, 2011. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Westin Alexandria, 400 Courthouse Square, Alexandria, VA 22314. Contact Person: Nadine Rogers, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4229, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892–9550, 301–402–2105, rogersn2@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, R01 and R34 Review. Date: June 30, 2011. Time: 11 a.m. to 2 p.m Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Nataly Strunnikova, PhD, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4237, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892–9550, 301–402–0288, strunnikovan@nei.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Medication Initiative for Tobacco Dependence (MITD): A New Product Development Partnership (PDP) (UH2/UH3). Date: July 7, 2011. Time: 8 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Gerald L. McLaughlin, PhD, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892–9550, 301–402–6626, gm145a@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: June 9, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–14868 Filed 6–15–11; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\16JNN1.SGM 16JNN1

Agencies

[Federal Register Volume 76, Number 116 (Thursday, June 16, 2011)]
[Notices]
[Page 35226]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-14868]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
USC, as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, 2011 NIDA Avant-Garde Award Program for HIV/AIDS 
Research (DP1).
    Date: June 28, 2011.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Westin Alexandria, 400 Courthouse Square, Alexandria, VA 
22314.
    Contact Person: Nadine Rogers, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 4229, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-402-2105, rogersn2@nida.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, R01 and R34 Review.
    Date: June 30, 2011.
    Time: 11 a.m. to 2 p.m
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Nataly Strunnikova, PhD, Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, Room 4237, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-402-0288, strunnikovan@nei.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Medication Initiative for Tobacco Dependence (MITD): 
A New Product Development Partnership (PDP) (UH2/UH3).
    Date: July 7, 2011.
    Time: 8 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-402-6626, gm145a@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: June 9, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-14868 Filed 6-15-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.